Fluence Announces Free Webinar on FDA’s MDMA-Assisted Therapy Decision
Fluence and Reunion Neuroscience Inc. Partners on RE104 Phase 2 in PPD
Oregon’s first psilocybin treatment center receives license, will start serving clients this month
Meet Oregon’s first psilocybin therapy facilitators
Could Psychedelics Revolutionize Addiction Treatment?
Psychotherapy & Integration – Fluence
Tryp Therapeutics Completes Psychotherapy Training for Planned Phase 2a Clinical Trial at Massachusetts General Hospital
EP 73: The Potential of Psychedelics to Help and Heal with Victor Cabral
PT394 – We Are The Medicine with Victor Cabral, LSW
Local Nonprofit Offers $50,000 in Scholarships for Psychedelics Guide Training
